Deferoxamine suppresses esophageal squamous cell carcinoma cell growth via ERK1/2 mediated mitochondrial dysfunction. [electronic resource]
Producer: 20190903Description: 132-143 p. digitalISSN:- 1872-7980
- Animals
- Apoptosis
- Carcinoma, Squamous Cell -- drug therapy
- Cell Movement
- Cell Proliferation
- Deferoxamine -- pharmacology
- Esophageal Neoplasms -- drug therapy
- Female
- Gene Expression Regulation, Neoplastic -- drug effects
- Humans
- Mice
- Mice, Nude
- Mitochondria -- drug effects
- Mitogen-Activated Protein Kinase 1 -- metabolism
- Mitogen-Activated Protein Kinase 3 -- metabolism
- Phosphorylation
- Reactive Oxygen Species -- metabolism
- Siderophores -- pharmacology
- Signal Transduction
- Tumor Cells, Cultured
- Xenograft Model Antitumor Assays
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.